BAYN.BRN Stock Chart & Stats
CHF179.00
CHF0.00(0.00%)
At close: 4:00 PM EDT
CHF179.00
CHF0.00(0.00%)
Day’s Range― - ―
52-Week RangeCHF179.00 - CHF179.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
CHF44.43B
Enterprise ValueCHF81.83K
Total Cash (Recent Filing)CHF5.08B
Total Debt (Recent Filing)CHF38.43B
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 03, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.76
Shares Outstanding982,424,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.40
Price to Sales (P/S)0.80
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF52.93Price Target Upside-70.43% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)4.21
Revenue Forecast (FY)CHF42.96B
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelBayer's dual focus in Pharmaceuticals and Crop Science provides durable revenue diversification across healthcare and agriculture. This reduces exposure to single-market cycles, leverages separate distribution channels and regulatory moats, and supports long-term cash generation and R&D reinvestment.
Cash GenerationConsistent positive operating and free cash flow despite recent net losses signals that core product sales convert to cash. Durable cash generation supports capital expenditure, R&D, dividend capacity and deleveraging options over the next several months, even if free cash flow is somewhat volatile.
High Gross MarginsSustained gross margins in the mid-50s to low-60s indicate strong underlying product economics and pricing power in key franchises. High gross margins provide a structural buffer against input cost shocks and fund R&D and commercialization, supporting medium-term margin recovery if operating costs are managed.
Bears Say
Elevated LeverageMulti-year leverage above equity limits financial flexibility and raises interest and refinancing risk. Elevated debt constrains strategic options such as large M&A or accelerated buybacks, increases sensitivity to macro shocks, and can pressure credit metrics and investment capacity over the medium term.
Multi-year Profitability WeaknessSustained net losses and inconsistent operating margins undermine return metrics and reinvestment capacity. Protracted profitability weakness can erode ROE, challenge dividend sustainability, and require either cost restructuring or higher-margin product launches to restore durable earnings power over the coming quarters.
Weak Revenue TrendSeveral years of flat-to-declining revenue before a recent TTM uptick suggest structural growth challenges from product lifecycles and cyclical Crop Science demand. Without steady top-line momentum, sustaining margins and funding innovation will be harder, leaving execution and new launches critical.
Bayer News
BAYN.BRN FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was CHF179.00 and its highest was CHF179.00 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is CHF44.43B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Nov 03, 2026 which is in 80 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Aug 04, 2026. The company reported CHF0.89 earnings per share for the quarter, beating the consensus estimate of CHF0.72 by CHF0.169.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Overvalued.
Does Bayer pay dividends?
Bayer does not currently pay dividends.
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 0.47.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of CHF0.89 in its last earnings report, beating expectations of CHF0.72. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in CH:BAYN.BRN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bayer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF52.93 (-70.43% Downside)
CHF52.93 (-70.43% Downside)
Blogger Sentiment
Bullish
CH:BAYN.BRN Sentiment 100%
Sector Average 59%
Sector Average 59%
Insider Transactions
Bought Shares
Worth CHF2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.03%
12-Months-Change
Fundamentals
Return on Equity
0.29%
Trailing 12-Months
Asset Growth
-1.13%
Trailing 12-Months
Company Description
Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
BAYN.BRN Stock 12 Month Forecast
Average Price Target
CHF52.93
▼(-70.43% Downside)